Baird Medical Investment Holdings Ltd Ordinary Share
BDMD
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
Last trade$0.0903
Day change-$0.0162 (-15.21%)
Day range$0.0895 – $0.094
Volume3,508,496
Market cap$3M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for BDMD.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for BDMD.
Recent news
Company coverage with links to the original publishers.
Baird Medical announced a strategic distribution partnership with ALLIS MED to serve as Korea License Holder and exclusive distributor of its microwave ablation products in South Korea following regulatory certification. The partnership marks another milestone in Baird Medical's global expansion strategy, with the company having entered multiple new markets in 2026 including Argentina, Egypt, Pakistan, and Vietnam, while also advancing its IRE-based products and AI-powered robotic ablation system.
Baird Medical announced medical device registrations in Vietnam and preliminary regulatory approval in Egypt for its microwave ablation technology. The company received Class C registration certificates in Vietnam for multiple MWA products including needles and generators, while the Egyptian Drug Authority granted preliminary approval for its BD-GT Microwave Ablation System. These milestones support the company's international expansion strategy beyond the U.S. and China markets.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.